I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Treatment With LAU-7b Complements CFTR Modulator Therapy by..:
Amanda Centorame
;
Daciana Catalina Dumut
;
Mina Youssef
...
https://www.frontiersin.org/articles/10.3389/fphar.2022.876842/full. , 2022
Link:
https://doi.org/10.3389/fphar.2022.876842
RT Journal T1
Treatment With LAU-7b Complements CFTR Modulator Therapy by Improving Lung Physiology and Normalizing Lipid Imbalance Associated With CF Lung Disease
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:e7cbeba9b2d34e6f99a2512513ff9ddf&Exemplar=1&LAN=DE A1 Amanda Centorame A1 Daciana Catalina Dumut A1 Mina Youssef A1 Martin Ondra A1 Irenej Kianicka A1 Juhi Shah A1 Radu Alexandru Paun A1 Tomas Ozdian A1 John W. Hanrahan A1 Ekaterina Gusev A1 Basil Petrof A1 Marian Hajduch A1 Radu Pislariu A1 Juan Bautista De Sanctis A1 Danuta Radzioch PB Frontiers Media S.A. YR 2022 K1 cystic fibrosis K1 LAU-7b K1 TRIKAFTA K1 ceramides K1 fenretinide (4-HPR) K1 sphingolipids K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.frontiersin.org/articles/10.3389/fphar.2022.876842/full LK http://dx.doi.org/https://doi.org/10.3389/fphar.2022.876842 DO https://doi.org/10.3389/fphar.2022.876842 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)